Leerink partners maintained a bullish stance on GoodRx stock, citing benefits from tariffs and onshoring trends.
2 reports, 1 independent
Updated Jul 11
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink partners maintained a bullish stance on GoodRx stock, citing benefits from tariffs and onshoring trends.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink partners maintained a bullish stance on GoodRx stock amid tariff and onshoring benefits for AI stocks.1 source
- GoodRx strategic outlook discussed: organizational changes and partnership deepening emphasized.
Keep exploring
Part of
Tariffs and onshoring trends are benefiting AI stocks, enabling production of specialized AI processors.Also in this story
- SkyWater Technology and IONQ are pursuing a pending merger agreement, with final voting results to be filed with the SEC.
- Fidelity National Information Services provides a post-trade processing platform to support AI stocks benefiting from tariffs and onshoring.
The entities involved
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyLeerink Partners Remains Bullish on GoodRx Holdings (GDRX) GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 13, Leerink Partners analyst Michael C
- Unknown outlet